Detection and characterization of focal hepatic lesions: comparative study of MDCT and gadobenate dimeglumine-enhanced MR imaging

Clinical Imaging

Volumn 32, Issue 4, 2008, Pages 287-295

  Lee, Ho Yun ^a   Lee, Jeong Min ^a   Kim, Se Hyung ^a   Shin, Kyung Sook ^b   Lee, Jae Young ^a   Han, Joon Koo ^a   Choi, Byung Ihn ^a  

^a Seoul National University College of Medicine   (South Korea)

^b Chungnam National University College of Medicine   (South Korea)

Author keywords

Computed tomography; Liver; Magnetic resonance imaging; Magnetic resonance, Comparative studies; Neoplasm

Indexed keywords

HEALTH; MAGNETIC FIELDS; MAGNETISM; RESONANCE;

COMPARATIVE STUDIES; DIAGNOSTIC PERFORMANCE; ELSEVIER (CO); FOCAL LIVER LESIONS; HELICAL CT; HEPATIC LESIONS; MAGNETIC RESONANCE (MR); MR IMAGING; RECEIVER OPERATING CHARACTERISTIC (ROC) CURVES;

COMPUTERIZED TOMOGRAPHY;

GADOBENATE DIMEGLUMINE;

ADULT; AGED; ALCOHOL LIVER DISEASE; ARTICLE; CHEMOEMBOLIZATION; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FEMALE; HEPATITIS B; HEPATITIS C; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER INJURY; MALE; MULTIDETECTOR COMPUTED TOMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

ADULT; AGED; CONTRAST MEDIA; FEMALE; HUMANS; LIVER DISEASES; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MEGLUMINE; MIDDLE AGED; ORGANOMETALLIC COMPOUNDS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 46249130851     PISSN: 08997071     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinimag.2007.11.004     Document Type: Article

References (37)

1. Reimer P., Jahnke N., Fiebich M., Schima W., Deckers F., Marx C., Holzknecht N., and Saini S. Hepatic lesion detection and characterization: value of nonenhanced MR imaging, superparamagnetic iron oxides-enhanced MR imaging, and spiral CT-ROC analysis. Radiology 217 (2000) 152-158
2. Quillin S., Atilla S., Brown J., Borrello J., Yu C., and Pilgram T. Characterization of focal hepatic masses by dynamic contrast-enhanced MR imaging: findings in 311 lesions. Magn Reson Imaging 15 (1997) 275-285
3. Fenlon H., Tello R., deCarvalho V., and Yucel E. Signal characteristics of focal liver lesions on double echo T2-weighted conventional spin echo MRI: observer performance versus quantitative measurements of T2 relaxation times. J Comput Assist Tomogr 24 (2000) 204-211
4. Brown J., Lee J., Lee J., Van Lorn K., and Malchow S. Focal hepatic lesions: differentiation with MR imaging at 0.5 T. Radiology 179 (1991) 675-679
5. Choi D., Kim S., Lim J., Lee W., Jang H., Lee S., and Lim H. Preoperative detection of hepatocellular carcinoma: ferumoxides-enhanced MR imaging versus combined CT during arterial portography and CT hepatic arteriography. AJR Am J Roentgenol 176 (2001) 475-482
6. Miller W., Baron R., Dodd G., and Federle M. Malignancies in patients with cirrhosis: CT sensitivity and specificity in 200 consecutive transplant patients. Radiology 193 (1994) 645-650
7. Ward J., Guthrie J., Scott D., Atchley J., Wilson D., Davies M., Wyatt J., and Robinson P. Hepatocellular carcinoma in the cirrhotic liver: double-contrast MR imaging for diagnosis. Radiology 216 (2000) 154-162
8. Hu H., He H., Foley W., and Fox S. Four multidetector-row helical CT: image quality and volume coverage speed. Radiology 215 (2000) 55-62
9. Murakami T., Kim T., Takamura M., Hori M., Takahashi S., Federle M., Tsuda K., Osuga K., Kawata S., Nakamura H., and Kudo M. Hypervascular hepatocellular carcinoma: detection with double arterial phase multi-detector row helical CT. Radiology 218 (2001) 763-767
10. Ichikawa T., Kitamura T., Nakajima H., Sou H., Tsukamoto T., Ikenaga S., and Araki T. Hypervascular hepatocellular carcinoma: can double arterial phase imaging with multidetector CT improve tumor depiction in the cirrhotic liver?. AJR Am J Roentgenol 179 (2002) 751-758
11. Schima W., Saini S., Echeverri J., Hahn P., Harisinghani M., and Mueller P. Focal liver lesions: characterization with conventional spin-echo versus fast spin-echo T2-weighted MR imaging. Radiology 202 (1997) 389-393
12. Lee V., Lavelle M., Krinsky G., and Rofsky N. Volumetric MR imaging of the liver and applications. Magn Reson Imaging Clin N Am 9 (2001) 697-716
13. Constable R. MR physics of body MR imaging. Radiol Clin North Am 41 (2003) 1-15
14. Weiger M., Boesiger P., Hilfiker P., Weishaupt D., and Pruessmann K. Sensitivity encoding as a means of enhancing the SNR efficiency in steady-state MRI. Magn Reson Med 53 (2005) 177-185
15. Pandharipandle P., Krinsky G., Rusineck H., and Lee V. Perfusion imaging of the liver: current challenges and future goals. Radiology 234 (2005) 661-673
16. Kirchin M., Pirovano G., and Spinazzi A. Gadobenate dimeglumine (Gd-BOPTA): an overview. Invest Radiol 33 (1998) 798-809
17. Cavagna F., Maggioni F., Castelli P., Dapra M., Imperatori L., Lorusso V., and Jenkins B. Gadolinium chelates with weak binding to serum proteins. A new class of high-efficiency, general purpose contrast agents for magnetic resonance imaging. Invest Radiol 32 (1997) 780-796
18. Petersein J., Spinazzi A., Giovagnoni A., Soyer P., Terrier F., Lencioni R., Bartolozzi C., Grazioli L., Chiesa A., Manfredi R., Marano P., Van Persijn Van Meerten E., Bloem J., Petre C., Marchal G., Greco A., McNamara M., Heuck A., Reiser M., Laniado M., Claussen C., Daldrup H., Rummeny E., Kirchin M., Pirovano G., and Hamm B. Focal liver lesions: evaluation of the efficacy of gadobenate dimeglumine in MR imaging: a multicenter phase III clinical study. Radiology 215 (2000) 727-736
19. Kim Y., Lee J., and Kim C. Gadobenate dimeglumine-enhanced liver MR imaging: value of dynamic and delayed imaging for the characterization and detection of focal liver lesions. Eur Radiol 14 (2004) 5-13
20. Kim Y., Kim C., Chung G., Kim C., and Kim I. Detection of liver metastases: gadovenate dimeglumine-enhanced three-dimensional dynamic phases and one-hour delayed phase MR imaging versus superparamagnetic iron oxide-enhanced MR imaging. Eur Radiol 15 (2005) 220-228
21. Obuchowski N. ROC analysis. AJR Am J Roentgenol 184 (2005) 364-372
22. Couinard C. Surgical anatomy of the liver: revisited (1989), Personal, Paris
23. Semelka R., Martin D., and Balci N. Focal lesions in normal liver. J Gastroeneterol Hepatol 20 (2005) 1478-1487
24. Semelka R., Martin D., Balci C., and Lance T. Focal liver lesions: comparison of dual-phase CT and multisequence multiplanar MR imaging including dynamic gadolinium enhancement. J Magn Reson Imaging 13 (2001) 397-401
25. Hori M., Murakami T., Kim T., Tomoda K., and Nakamura H. CT scan and MRI in the differentiation of liver tumors. Dig Dis 22 (2004) 39-55
26. Baron R., Oliver J., Dodd G., Nalesnik M., Holbert B., and Carr B. Hepatocellular carcinoma: evaluation with biphasic, contrast-enhanced, helical CT. Radiology 199 (1996) 505-511
27. Kim M., Kim J., Chung J., Park M., Lim J., and Oh Y. Focal hepatic lesions: detection and characterization with combination gadolinium- and superparamagnetic iron oxide-enhanced MR imaging. Radiology 228 (2003) 719-726
28. Krinsky G., Lee V., Theise N., Weinreb J., Rofsky N., Diflo T., and Teperman L. Hepatocellular carcinoma and dysplastic nodules in patients with cirrhosis: prospective diagnosis with MR imaging and explantation correlation. Radiology 219 (2001) 445-454
29. Earls J., Theise N., Weinreb J., DeCorato D., Krinsky G., Rofsky N., Mizrachi H., and Teperman L. Dysplastic nodules and hepatocellular carcinoma: thin-section MR imaging of explanted cirrhotic livers with pathologic correlation. Radiology 201 (1996) 207-214
30. Jang H., Lim J., Lee S., Park C., Park H., and Do Y. Hepatocellular carcinoma: are combined CT during arterial portography and CT hepatic arteriography in addition to triple-phase helical CT all necessary for preoperative evaluation?. Radiology 215 (2000) 373-380
31. Kang B., Lim J., Kim S., Choi D., Lim H., Lee W., and Lee S. Preoperative depiction of hepatocellular carcinoma: ferumoxides-enhanced MR imaging versus triple-phase helical CT. Radiology 226 (2003) 79-85
32. Kim S., Choi D., Kim S., Lim J., Lee W., Kim M., Lim H., and Lee S. Ferucarbotran-enhanced MRI versus triple-phase MDCT for the preoperative detection of hepatocellular carcinoma. AJR Am J Roentgenol 184 (2005) 1069-1076
33. Kundel H., and Polansky M. Measurement of observer agreement. Radiology 228 (2003) 303-308
34. Kim Y., Kim C., Chung G., Han Y., Lee S., Chon S., and Lee J. Comparison of gadobenate dimeglumine-enhanced dynamic MRI and 16-MDCT for the detection of hepatocellular carcinoma. AJR Am J Roentgenol 186 (2006) 149-157
35. Holland A., Hecht E., Hahn W., Kim D., Babb J., Lee V., West A., and Krinsky G. Importance of small (< or = 20-mm) enhancing lesions seen only during the hepatic arterial phase at MR imaging of the cirrhotic liver: evaluation and comparison with whole explanted liver. Radiology 237 (2005) 938-944
36. Coates G., Borrello J., McFarland E., Mirowitz S., and Brown J. Hepatic T2-weighted MRI: a prospective comparison of sequences, including breath-hold, half-Fourier turbo spin echo (HASTE). J Magn Reson Imaging 8 (1998) 642-649
37. Imanishi Y., Fukui A., Niimi H., Itoh D., Nozaki K., Nakaji S., Ishizuka K., Tabata H., Furuya Y., Uzura M., Takahama H., Hashizume S., Arima S., and Nakajima Y. Radiation-induced temporary hair loss as a radiation damage only occurring in patients who had the combination of MDCT and DSA. Eur Radiol 15 (2005) 41-46